Does Laparoscopic Sleeve Gastrectomy Lead to Barrett's Esophagus, 5-year Esophagogastroduodenoscopy Findings: A Retrospective Cohort Study

Eliana Al Haddad92 enrolled

Overview

Introduction Laparoscopic Sleeve Gastrectomy (LSG) is one of the most prevalent approaches to tackle obesity and its co-morbidities. The main complication following the LSG is Gastro-esophageal reflux disease (GERD), with most patients developing worsening symptoms of GERD, and a small number progressing to Barrett's esophagus. This retrospective analysis aims to assess the rate of GERD pre- and post- LSG as well as the rate of progression to Barrett's. Methods Data was collected from 1639 patients. 92 patients fit our inclusion criteria. Data was then analyzed and summarized against similar literature

Study Type

OBSERVATIONAL

Enrollment

Conditions

Barrett Esophagus

Interventions

Laparoscopic Sleeve GastrectomyDIAGNOSTIC_TEST

bariatric surgery

Eligibility

Sex: ALLMin age: 24 YearsMax age: 36 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients eligible to sleeve gastrectomy that had an EGD pre and 5 years post-op Exclusion Criteria: * missing or implausible data, had multiple surgeries, and suffered from the common post-sleeve complications, such as leaks, strictures and hiatal hernias

Outcomes

Primary Outcomes

endoscopy performed on patients

endoscopy will be performed on patients 5 years after undergoing sleeve gastrectomy due to the fact that sleeve tends to lead to reflux which causes dysplasia of esophageal cells, which eventually can lead to barrett's esophagus and cancer.

Time frame: 5 years